Difference between revisions of "WSI24-422-Case-3"

From MGH Learn Pathology
(Creating page)
 
Line 1: Line 1:
 
{{ServiceRequestCase
 
{{ServiceRequestCase
|identifier=WSI24-422-Case-3
+
|subject=MGH
 
|intent=order
 
|intent=order
 +
|category=409073007
 +
|occurrenceDateTime=2026-02-03T20:00:00+00:00
 +
|basedOn=WSI24-422
 +
|priority=Routine
 
|code=apdidactic
 
|code=apdidactic
|category=409073007
+
|orderDetail=case
|subject=MGH
+
|authoredOn=2026-02-03T17:31:47.867463+00:00
 
|requester=Kx601
 
|requester=Kx601
 +
|locationCode=learn
 +
|sequence=3
 
|performer=Mjf12
 
|performer=Mjf12
|orderDetail=case
+
|bodySite=BREAST MASTECTOMY
|locationCode=learn
+
|reasonCode=34 yo F with invasive ductal carcinoma, s/p neoadjuvant therapy, extensive LVI
 +
|supportingInfo=HER2 IHC:  2+
 +
HER2 FISH:  Not amplified
 +
Ratio = 1.2, 3.2/2.5, Group 5
 +
|identifier=WSI24-422-Case-3
 
|access=public
 
|access=public
 
|status=active
 
|status=active
 
|origin=CPOE
 
|origin=CPOE
|priority=Routine
 
|basedOn=WSI24-422
 
|requisition=
 
|reasonCode=history
 
|occurrenceDateTime=2026-02-03T20:00:00+00:00
 
|authoredOn=2026-02-03T17:31:47.867463+00:00
 
|specimen=
 
|sequence=3
 
|supportingInfo=diagnosis
 
|bodySite=
 
|replaces=
 
}}
 
{{status
 
|status=active
 
|requester=Kx601
 
|authoredOn=2026-02-03T17:31:47.867463+00:00
 
 
}}
 
}}
 
{{Media
 
{{Media
|identifier=b601aa93-d270-4206-9d44-bc937be72fa6
 
|basedOn=WSI24-422-Case-3
 
|status=completed
 
|frames=1
 
|operator=Kx601
 
|reasonCode=
 
|content=c9b8bef4-5fa0-4a75-9b35-cac9af96308b.mrxs
 
|view=show
 
 
|createdDateTime=2026-02-03T17:31:47.867463+00:00
 
|createdDateTime=2026-02-03T17:31:47.867463+00:00
}}
 
 
{{Media
 
|identifier=4a1c6043-2bda-4086-ac7f-ab08df22aa3f
 
|basedOn=WSI24-422-Case-3
 
|status=completed
 
|frames=2
 
 
|operator=Kx601
 
|operator=Kx601
|reasonCode=
+
|frames=3
|content=2a2b1310-2994-478c-8ec3-a7e5e0aef5b0.mrxs
 
|view=show
 
|createdDateTime=2026-02-03T17:31:47.867463+00:00
 
}}
 
 
 
{{Media
 
|identifier=b3b0bda3-6860-47a8-aba0-4aaa77f4fd33
 
|basedOn=WSI24-422-Case-3
 
 
|status=completed
 
|status=completed
|frames=3
 
|operator=Kx601
 
 
|reasonCode=HER2 Quant Breast
 
|reasonCode=HER2 Quant Breast
|content=87fcd4ae-6c3e-4c2c-9c68-dbce080a559d.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2026-02-03T17:31:47.867463+00:00
+
|identifier=b3b0bda3-6860-47a8-aba0-4aaa77f4fd33
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=1db7c315-9721-429d-89dc-845624da02a3
+
|createdDateTime=2026-02-03T17:31:47.867463+00:00
|basedOn=WSI24-422-Case-3
+
|operator=Kx601
 +
|frames=4
 
|status=completed
 
|status=completed
|frames=4
 
|operator=Kx601
 
|reasonCode=HE Recut 4um Breast
 
|content=c9adc456-8ee0-46da-837b-321c1464d5f3.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2026-02-03T17:31:47.867463+00:00
+
|identifier=1db7c315-9721-429d-89dc-845624da02a3
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Kx601
 +
|authoredOn=2026-02-03T17:31:47.867463+00:00
 
}}
 
}}

Revision as of 13:55, February 3, 2026

WSI24-422-Case-3
34 yo F with invasive ductal carcinoma, s/p neoadjuvant therapy, extensive LVI
HER2 IHC: 2+

HER2 FISH: Not amplified

Ratio = 1.2, 3.2/2.5, Group 5
February 6, 2026 2:00:00 PM